Novel gene mutation causing type 3 Von Willebrand disease: a case report and review of literature
Keywords:Hemophilia, Factor-viii, VWF, VWD, Hemarthrosis
Von Willebrand disease (VWD) Type 3 is an uncommon bleeding disorder, resulting from the near absence of Von Willebrand factor (VWF) and extremely low factor-VIII levels. It is a close differential diagnosis of hemophilia. A wide heterogeneity of VWD mutations are reported in the literature. We report a 16-year-old girl with hemarthrosis, finally diagnosed with Type 3 VWD. Clinical exome sequencing confirmed the diagnosis, revealing a homozygous mutation c.4387G>T (p. Glu1463Ter) in exon 28 of the VWF gene, a unique mutation not yet reported in the literature.
Michael Soucie J, Miller CH, Byams VR, Payne AB, Abe K, Sidonio RF Jr, Kouides PA: Occurrence rates of von Willebrand disease among people receiving care in specialized treatment centres in the United States. Haemophilia. 2021, 27:445-53.
Montgomery RR, Gill JC: Interactions between von Willebrand factor and factor VIII: where did they first meet. J Pediatr Hematol Oncol. 2021;22:269-275.
Sadler JE, Budde U, Eikenboom JC. Update on the p physiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost. 2006;4:2103-14.
Eikenboom JC. Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology. Best Pract Res Clin Haematol. 2001;14:365-79.
Mandava M, Bergmann S, Lazarchick J. A Novel Case of Compound Heterozygous Type 3 Von Willebrand Disease. Ann Clin Lab Sci. 2019;49:393-4.
Bowman M, Hopman WM, Rapson D, Lillicrap D, James P. The prevalence of symptomatic von Willebrand disease in primary care practice. J Thromb Haemost. 2010;8:213-6.
Trasi S, Shetty S, Ghosh K, Mohanty D: Prevalence and spectrum of von Willebrand disease from western India. Indian J Med Res. 2005;121:653-8.
Tosetto A, Badiee Z, Baghaipour MR. Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: Results from 3WINTERS-IPS, an international and collaborative cross-sectional study. J Thromb Haemost. 2020;18:2145-54.
Kasatkar P, Shetty S, Ghosh K. Genetic heterogeneity in a large cohort of Indian type 3 von Willebrand disease patients. PLoS One. 2014;27:92575.
James PD, Lillicrap D, Mannucci PM. Alloantibodies in von Willebrand disease. Blood. 2013;122:636-40.